Industry Analysis: Spirometry and PFT in the Era of COVID-19
Overview
The COVID-19 pandemic has significantly impacted spirometry and pulmonary function testing (PFT) markets.
Discussion with key executives from MGC Diagnostics, NDD Medical, Vitalograph Inc, and Medical International Research (MIR) highlights effects on the industry.
Key Topics Discussed
Factors for Purchasing Spirometry and PFT Equipment
Infection Control: Crucial to ensure equipment can be easily cleaned and disinfected.
Flow Sensor Efficiency: Compatibility between spirometers and PFT systems is important for consistent results.
Ease of Use: Software should guide technicians through procedures.
Standards Compliance: Equipment should meet ATS/ERS 2019 standards.
Cost and Warranty Considerations: Consumable costs, warranty details, and potential hidden costs should be evaluated.
Increasing Access to Spirometry
Home Testing: Remote Patient Monitoring can improve access, allowing patients to test themselves at home.
Portable Devices: Necessary for underserved and rural areas to enhance access.
Education and Training: Increasing awareness about spirometry importance and training for consistent testing.